Literature DB >> 8986720

Fas modulation of apoptosis during negative selection of thymocytes.

J E Castro1, J A Listman, B A Jacobson, Y Wang, P A Lopez, S Ju, P W Finn, D L Perkins.   

Abstract

A major mechanism maintaining immune tolerance is the deletion of potentially autoreactive thymocytes by apoptosis during development in the thymus. Previous reports suggest that apoptosis is induced by high avidity signals transduced via the T cell receptor; however, the role of signals transduced by other cell surface receptors during thymic selection remains poorly understood. Fas, a member of the TNF receptor family, has been shown to induce apoptosis in mature peripheral T cells; however, the effects of Fas on negative selection of thymocytes have not been previously detected. Using a sensitive terminal deoxynucleotidyl transferase method to detect apoptotic cells, we found that mutant Fas molecules in lpr mice decrease the sensitivity of thymocytes to T cell receptor-mediated apoptosis and that blockade of Fas-Fas ligand interactions in vivo can inhibit antigen-induced apoptosis of thymocytes in non-lpr mice. Thus, we have shown that Fas, in conjunction with antigen-specific signals, can modulate apoptosis during negative selection of thymocytes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8986720     DOI: 10.1016/s1074-7613(00)80275-7

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  35 in total

Review 1.  TRAIL, Bim, and thymic-negative selection.

Authors:  Shi-Jun Zheng; Youhai H Chen
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

2.  Molecular cloning and characterisation of the rock bream, Oplegnathus fasciatus, Fas (CD95/APO-1), and its expression analysis in response to bacterial or viral infection.

Authors:  Ji-Min Jeong; Ju-Won Kim; Hyoung-Jun Park; Jeong-Hun Song; Do-Hyung Kim; Chan-Il Park
Journal:  Results Immunol       Date:  2011-07-14

3.  Human cytotoxic T lymphocytes with reduced sensitivity to Fas-induced apoptosis.

Authors:  Gianpietro Dotti; Barbara Savoldo; Martin Pule; Karin C Straathof; Ettore Biagi; Eric Yvon; Stephane Vigouroux; Malcolm K Brenner; Cliona M Rooney
Journal:  Blood       Date:  2005-02-15       Impact factor: 22.113

4.  Tumor necrosis factor-related apoptosis-inducing ligand in T cell development: sensitivity of human thymocytes.

Authors:  A K Simon; O Williams; J Mongkolsapaya; B Jin; X N Xu; H Walczak; G R Screaton
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-17       Impact factor: 11.205

5.  The calcium-independent protein kinase C participates in an early process of CD3/CD28-mediated induction of thymocyte apoptosis.

Authors:  A Asada; Y Zhao; H Komano; T Kuwata; M Mukai; K Fujita; Y Tozawa; R Iseki; H Tian; K Sato; Y Motegi; R Suzuki; M Yokoyama; M Iwata
Journal:  Immunology       Date:  2000-11       Impact factor: 7.397

Review 6.  Autoreactive T cells in murine lupus: origins and roles in autoantibody production.

Authors:  J Craft; S Peng; T Fujii; M Okada; S Fatenejad
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

Review 7.  Immunological self/nonself discrimination: integration of self vs nonself during cognate T cell interactions with antigen-presenting cells.

Authors:  M D Mannie
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

8.  LARD: a new lymphoid-specific death domain containing receptor regulated by alternative pre-mRNA splicing.

Authors:  G R Screaton; X N Xu; A L Olsen; A E Cowper; R Tan; A J McMichael; J I Bell
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

9.  Stress-induced Fas ligand expression in T cells is mediated through a MEK kinase 1-regulated response element in the Fas ligand promoter.

Authors:  M Faris; K M Latinis; S J Kempiak; G A Koretzky; A Nel
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

10.  Blocked negative selection of developing T cells in mice expressing the baculovirus p35 caspase inhibitor.

Authors:  M Izquierdo; A Grandien; L M Criado; S Robles; E Leonardo; J P Albar; G G de Buitrago; C Martínez-A
Journal:  EMBO J       Date:  1999-01-04       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.